No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Tristel announced the appointment of Christopher Lee as its chief executive officer on Wednesday, effective 1 August, following a competitive selection process.
The AIM-traded infection prevention products maker said Lee would replace Matt Sassone, who is leaving on 30 June to take a worldwide president role with a large US multinational.
Chief financial officer Anna Wasyl will act as interim CEO until Lee joins.
Lee was most recently chief executive of Summit Medical from 2020 to 2025 and previously led Venner Medical International.
Chair Bruno Holthof said Lee's medical technology experience, "especially in the US", made him "the ideal person to lead the business" as Tristel pursues further overseas growth.
At 0937 BST, shares in Tristel were down 1.1% at 380.75p.
Reporting by Josh White for Sharecast.com.
See latest RNS on Investegate
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.